BIOXCEL THERAPEUTICS - DEAL WITH TEVA INCLUDES $57.5 MLN CASH, UP TO $67.5 MLN DEVELOPMENT MILESTONES, $20 MLN COMMERCIAL MILESTONES - SEC FILING

Reuters · 3d ago

Please log in to view news